Pharmacokinetic-Moedeling
Showing 1 - 25 of 5,569
TB Drugs and Bacterial Drug Resistance
Completed
- Tuberculosis
- Non-Tuberculosis Mycobacteria
-
Bethesda, Maryland
- +1 more
Mar 25, 2022
Tuberculosis, Latent Tuberculosis, Nontuberculous Mycobacterium Infection Trial in Busan (therapeutic drug monitoring(TDM))
Recruiting
- Tuberculosis
- +2 more
- therapeutic drug monitoring(TDM)
-
Busan, Korea, Republic ofInje University Busan Paik Hoapital Clinical Trial Center
Mar 6, 2022
Rituximab in Children With Blood Diseases
Not yet recruiting
- Rituximab
- +2 more
- Rituximab
- Rituximab (once a week)
- (no location specified)
Apr 8, 2022
Anti-Ulcer Agents Trial in Gyeonggi-do (coadministration of JP-1366 and aceclofenac, coadministration of JP-1366 and meloxicam,
Completed
- Anti-Ulcer Agents
- coadministration of JP-1366 and aceclofenac
- +3 more
-
Gyeonggi-do, Korea, Republic ofCha University Bundang Medical Center
Jun 28, 2022
Contraception Trial in Aurora (Desogestrel and Ethinyl Estradiol Tablets)
Recruiting
- Contraception
- Desogestrel and Ethinyl Estradiol Tablets
-
Aurora, ColoradoUniversity of Colorado Denver
Mar 8, 2022
Opioid Dependence, Alcohol Dependence Trial (Vivitrol Injectable Product, IVL3004)
Not yet recruiting
- Opioid Dependence
- Alcohol Dependence
- Vivitrol Injectable Product
- IVL3004
- (no location specified)
Nov 10, 2022
Solid Tumor Trial in Cheongju-si (High-fat meal (over 900 kcal), ABN401 (investigational product))
Recruiting
- Solid Tumor
- High-fat meal (over 900 kcal)
- ABN401 (investigational product)
-
Cheongju-si, Seowon-gu, Korea, Republic ofChungbuk National University Hospital
Feb 23, 2022
Preeclampsia Trial in Philadelphia (Aspirin 81Mg Non-enteric coated Tab)
Active, not recruiting
- Preeclampsia
- Aspirin 81Mg Non-enteric coated Tab
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Aug 15, 2022
Port-wine Stain Trial in Shanghai (Hemoporfin PDT)
Recruiting
- Port-wine Stain
- Hemoporfin PDT
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital, Shanghai JiaoTong University S
Mar 14, 2022
Patients With Mild or Moderate Hepatic Impairment Trial in Tokyo (TS-142 5 mg)
Recruiting
- Patients With Mild or Moderate Hepatic Impairment
- TS-142 5 mg
-
Tokyo, JapanTaisho Pharmaceutical Co., Ltd selected site
Dec 27, 2022
Hyperlipidemias Trial in Seoul (AD-104-A)
Not yet recruiting
- Hyperlipidemias
-
Seoul, Jongno-gu, Korea, Republic ofSeoul National University Hospital
Jan 26, 2023
Diabetic Nephropathy Trial in Changchun (HEC73077 tablets, HEC73077 tablets)
Recruiting
- Diabetic Nephropathy
- HEC73077 tablets
- HEC73077 placebo tablets
-
Changchun, Jilin, ChinaThe First Hospital of Jilin University
Aug 5, 2022
Latrodectism Trial in Ciudad de mexico (ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder
Completed
- Latrodectism
- ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder for solution 10 mL
-
Ciudad de mexico, Mexico City, MexicoLaboratorio Silanes, S.A. de C.V.
Feb 28, 2022
Systemic Lupus Erythematosus Trial in Nantong, Shanghai (Anifrolumab)
Completed
- Systemic Lupus Erythematosus
- Anifrolumab
-
Nantong, China
- +2 more
Aug 17, 2022
Contraception Trial in Aurora (Etonogestrel implant)
Completed
- Contraception
- Etonogestrel implant
-
Aurora, ColoradoUniversity of Colorado Denver
May 16, 2022
Drug Interaction Potentiation Trial in Seoul (Ilaprazole, Aceclofenac)
Not yet recruiting
- Drug Interaction Potentiation
-
Seoul, Korea, Republic ofSeverance Hospital
Sep 23, 2022
Healthy Adult Male Trial in Beijing (OPC-61815 injection)
Recruiting
- Healthy Adult Male
- OPC-61815 injection
-
Beijing, ChinaClinical Pharmacology Research Center, Peking Union Medical Coll
Jul 4, 2022
Alopecia Trial in Seoul (CKD-843 A, CKD-843 B, CKD-843-R)
Completed
- Alopecia
- CKD-843 A
- +2 more
-
Seoul, Korea, Republic ofSeverance Hospital
Apr 5, 2022